262 related articles for article (PubMed ID: 8257633)
21. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
Naryshkin NA; Gait MJ; Ivanovskaya MG
Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
[TBL] [Abstract][Full Text] [Related]
22. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
[TBL] [Abstract][Full Text] [Related]
23. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
Taylor JP; Kundu M; Khalili K
Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
[TBL] [Abstract][Full Text] [Related]
24. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
Jayasena SD; Johnston BH
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
[TBL] [Abstract][Full Text] [Related]
25. Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR.
Luo Y; Peterlin BM
J Virol; 1993 Jun; 67(6):3441-5. PubMed ID: 8497060
[TBL] [Abstract][Full Text] [Related]
26. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
Tao J; Frankel AD
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
[TBL] [Abstract][Full Text] [Related]
27. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
[TBL] [Abstract][Full Text] [Related]
28. Molecular approaches to inhibit HIV-1 tat expression and functions.
Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
[No Abstract] [Full Text] [Related]
29. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
J Virol; 1999 Jul; 73(7):5777-86. PubMed ID: 10364329
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
31. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells.
Reddy TR; Suhasini M; Rappaport J; Looney DJ; Kraus G; Wong-Staal F
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):663-9. PubMed ID: 7576925
[TBL] [Abstract][Full Text] [Related]
33. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
Rittner K; Churcher MJ; Gait MJ; Karn J
J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
Song CZ; Loewenstein PM; Green M
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
[TBL] [Abstract][Full Text] [Related]
35. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
Calnan BJ; Biancalana S; Hudson D; Frankel AD
Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
Rana TM; Jeang KT
Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
[TBL] [Abstract][Full Text] [Related]
37. The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression.
Kim YS; Panganiban AT
J Virol; 1993 Jul; 67(7):3739-47. PubMed ID: 8510203
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 tat transcriptional activity is regulated by acetylation.
Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
[TBL] [Abstract][Full Text] [Related]
39. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
Kolson DL; Collman R; Hrin R; Balliet JW; Laughlin M; McGann KA; Debouck C; Gonzalez-Scarano F
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1927-34. PubMed ID: 8046394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
